Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Stephen Remondi
AddedMar 31, 2024
UpdatedMay 31, 2026
Stephen Remondi

Stephen Remondi

CEO, Exa Ventures

CrunchbaseLinkedIn

Stephen Remondi's Career

Exa Ventures
Exa Ventures

Cupertino, CA, US

CEO· C-Suite · Management
Aeye Health
Aeye Health

New York City, NY, US

Board Member· Board
Xsphera Biosciences
Xsphera Biosciences

Boston, MA, US

Co-Founder & CEO· C-Suite · Management

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Stephen Remondi's Career

Exa Ventures
Exa Ventures
Investment FirmInvestment Firm15Cupertino, CA, US
CEO· C-Suite · Management
Aeye Health
Aeye Health
Seed$10M202018New York City, NY, US
Board Member· Board

Leadership at Aeye Health

Zack Dvey-AharonZack Dvey-AharonCo-Founder
Sean IanchulevSean IanchulevBoard Member
Mike NetzMike NetzBoard Member
Danny MargalitDanny MargalitCo-Founder

Similar to Aeye Health

Altris.AIAltris.AIChicago, IL, USMedical Softwareest. 2018Altris.AIChicago, IL, US · est. 2018

Deep learning SaaS and mobile app for automated detection and analysis of ocular diseases.

Pre-Seed · $1M13
Ocular DiagnosticsOcular DiagnosticsNew York City, NY, USAI Diagnosticsest. 2021Ocular DiagnosticsNew York City, NY, US · est. 2021

AI-powered company providing accurate and efficient diagnostics for ADHD.

Seed · $130k6
Xsphera Biosciences
Xsphera Biosciences
Series B$17.6M242018Boston, MA, US
Co-Founder & CEO· C-Suite · Management

Leadership at Xsphera Biosciences

David BarbieDavid BarbieCo-Founder
Mike PerriconeMike PerriconeCo-Founder
Russ JenkinsRuss JenkinsCo-Founder
Jennifer Levin CarterJennifer Levin CarterBoard Member

Stephen Remondi's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · Dunamu

People Similar to Stephen Remondi

Paul CastellaPaul CastellaBoard Member · Hera BiotechJim KnightonJim KnightonCo-Founder · AvidbioticsFranklin BostFranklin BostCEO · SpheringenicsJeff RichJeff RichCo-Founder · Hemisphere VenturesStephen TurnerStephen TurnerBoard Member · Protea BiosciencesCory BerklandCory BerklandBoard Member · Orion BioScience